Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Thomas Melchardt; Teresa Magnes; Clemens Hufnagl; Aaron R Thorner; Matthew Ducar; Daniel Neureiter; Wolfgang Tränkenschuh; Eckhard Klieser; Alexander Gaggl; Sebastian Rösch; Gerd Rasp; Tanja Hartmann; Lisa Pleyer; Gabriel Rinnerthaler; Lukas Weiss; Richard Greil; Alexander Egle

doi:10.1016/j.ejca.2018.01.064

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Thomas Melchardt (First author), Teresa Magnes (Co-author), Clemens Hufnagl (Co-author), Aaron R Thorner, Matthew Ducar, Daniel Neureiter (Co-author), Wolfgang Tränkenschuh, Eckhard Klieser (Co-author), Alexander Gaggl (Co-author), Sebastian Rösch (Co-author), Gerd Rasp (Co-author), Tanja Hartmann (Co-author), Lisa Pleyer (Co-author), Gabriel Rinnerthaler (Co-author), Lukas Weiss (Co-author), Richard Greil (Co-author), Alexander Egle^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

25 Citations (Web of Science)

Original language	English
Pages (from-to)	69-78
Journal	EUROPEAN JOURNAL OF CANCER
Volume	93
DOIs	https://doi.org/10.1016/j.ejca.2018.01.064
Publication status	Published - 2018

Keywords

SQUAMOUS-CELL CARCINOMA
MUTATIONAL LANDSCAPE
LYMPHOMA
SURVIVAL
GENES
TITIN

Access to Document

10.1016/j.ejca.2018.01.064

Toxicity and outcome with induction chemotherapy in patients with advanced head and neck cancer
Melchardt, T. (PI)
1/02/14 → 1/02/15
Project: Research

Cite this

Melchardt, T., Magnes, T., Hufnagl, C., Thorner, A. R., Ducar, M., Neureiter, D., Tränkenschuh, W., Klieser, E., Gaggl, A., Rösch, S., Rasp, G., Hartmann, T., Pleyer, L., Rinnerthaler, G., Weiss, L., Greil, R., & Egle, A. (2018). Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. EUROPEAN JOURNAL OF CANCER , 93, 69-78. https://doi.org/10.1016/j.ejca.2018.01.064

Melchardt, Thomas ; Magnes, Teresa ; Hufnagl, Clemens et al. / Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. In: EUROPEAN JOURNAL OF CANCER 2018 ; Vol. 93. pp. 69-78.

@article{143ca9ee067a4a21ad988ef530f4da3f,

title = "Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.",

keywords = "SQUAMOUS-CELL CARCINOMA, MUTATIONAL LANDSCAPE, LYMPHOMA, SURVIVAL, GENES, TITIN",

author = "Thomas Melchardt and Teresa Magnes and Clemens Hufnagl and Thorner, {Aaron R} and Matthew Ducar and Daniel Neureiter and Wolfgang Tr{\"a}nkenschuh and Eckhard Klieser and Alexander Gaggl and Sebastian R{\"o}sch and Gerd Rasp and Tanja Hartmann and Lisa Pleyer and Gabriel Rinnerthaler and Lukas Weiss and Richard Greil and Alexander Egle",

note = "Melchardt, Magnes, Hufnagl, Hartmann, Pleyer, Rinnerthaler, Weiss, Greil, Egle: Med Dept Hematol & Med Oncol 3; Neureiter, Traenkenschuh, Klieser: Dept Pathol; Gaggl: Dept Oral & Maxillofacial Surg; Roesch, Rasp: Dept Otorhinolaryngol; all: Paracelsus Med Univ, Salzburg, Austria",

year = "2018",

doi = "10.1016/j.ejca.2018.01.064",

language = "English",

volume = "93",

pages = "69--78",

journal = "EUROPEAN JOURNAL OF CANCER ",

issn = "0959-8049",

publisher = "Elsevier ",

}

Melchardt, T , Magnes, T , Hufnagl, C, Thorner, AR, Ducar, M, Neureiter, D, Tränkenschuh, W, Klieser, E , Gaggl, A , Rösch, S , Rasp, G, Hartmann, T, Pleyer, L , Rinnerthaler, G , Weiss, L , Greil, R & Egle, A 2018, 'Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.', EUROPEAN JOURNAL OF CANCER , vol. 93, pp. 69-78. https://doi.org/10.1016/j.ejca.2018.01.064

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. / Melchardt, Thomas (First author); Magnes, Teresa (Co-author); Hufnagl, Clemens (Co-author) et al.
In: EUROPEAN JOURNAL OF CANCER , Vol. 93, 2018, p. 69-78.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

AU - Melchardt, Thomas

AU - Magnes, Teresa

AU - Hufnagl, Clemens

AU - Thorner, Aaron R

AU - Ducar, Matthew

AU - Neureiter, Daniel

AU - Tränkenschuh, Wolfgang

AU - Klieser, Eckhard

AU - Gaggl, Alexander

AU - Rösch, Sebastian

AU - Rasp, Gerd

AU - Hartmann, Tanja

AU - Pleyer, Lisa

AU - Rinnerthaler, Gabriel

AU - Weiss, Lukas

AU - Greil, Richard

AU - Egle, Alexander

N1 - Melchardt, Magnes, Hufnagl, Hartmann, Pleyer, Rinnerthaler, Weiss, Greil, Egle: Med Dept Hematol & Med Oncol 3; Neureiter, Traenkenschuh, Klieser: Dept Pathol; Gaggl: Dept Oral & Maxillofacial Surg; Roesch, Rasp: Dept Otorhinolaryngol; all: Paracelsus Med Univ, Salzburg, Austria

PY - 2018

Y1 - 2018

KW - SQUAMOUS-CELL CARCINOMA

KW - MUTATIONAL LANDSCAPE

KW - LYMPHOMA

KW - SURVIVAL

KW - GENES

KW - TITIN

U2 - 10.1016/j.ejca.2018.01.064

DO - 10.1016/j.ejca.2018.01.064

M3 - Original Article (Journal)

C2 - 29477794

SN - 0959-8049

VL - 93

SP - 69

EP - 78

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

ER -

Melchardt T , Magnes T , Hufnagl C, Thorner AR, Ducar M, Neureiter D et al. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. EUROPEAN JOURNAL OF CANCER . 2018;93:69-78. doi: 10.1016/j.ejca.2018.01.064

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Keywords

Access to Document

Projects

Toxicity and outcome with induction chemotherapy in patients with advanced head and neck cancer

Cite this